Skip to main content

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Changes of Serum IgG Dimer Levels after Treatment with IVIg in Guillain-Barré Syndrome

Include preview-only content
  1. Article

    Open Access

    Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)

    The composition of gut microbiota plays a pivotal role in priming the immune system and thus impacts autoimmune diseases. Data on the effects of gut bacteria eradication via systemic antibiotics on immune neur...

    Alina Sprenger-Svačina, Ines Klein in Journal of Neuroimmune Pharmacology (2024)

  2. Article

    Open Access

    Kinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis

    Autoimmune neuropathies can result in long-term disability and incomplete recovery, despite adequate first-line therapy. Kinesin-5 inhibition was shown to accelerate neurite outgrowth in different preclinical ...

    Felix Kohle, Robin Ackfeld, Franziska Hommen, Ines Klein in Journal of Neuroinflammation (2023)

  3. Article

    Open Access

    CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study

    Availability of COVID-19 mRNA vaccine for patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg) raises the question of whether COVID-19 mRNA vac...

    Martin K. R. Svačina, Anika Meißner in Journal of Neuroimmune Pharmacology (2023)

  4. Article

    Open Access

    Could symptom overlap of COVID-19 and Guillain–Barré syndrome mask an epidemiological association?

    Martin K. R. Svačina, Felix Kohle, Alina Sprenger in Journal of Neurology (2021)